End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of VizTM Vascular Suite, AI-powered software enabling vascular care teams to automatically detect and triage care for suspected […]
Tag: Viz.Ai
Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making
New partnership incorporates latest perfusion technology into the Viz.ai platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will incorporate Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion […]
Viz.ai Launches AI-powered Viz™ Radiology Suite
Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the introduction of an AI-powered radiology suite, specifically designed to alert the radiologist in their workflow of suspected diseases, prioritize worklists, and connect care […]
Viz.ai Appoints Radiology Advisory Board to Advance Innovation
Leading experts to help shape the future of Viz.ai’s radiology strategy and platform SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the creation of its Radiology Advisory Board to assist Viz.ai in the development of strategy and products to support radiologists and patients. […]
Viz.ai™ Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium™
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value SAN FRANCISCO & NEW YORK–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new data from a large aortic dissection artificial intelligence real-world study that supports the use of its […]
Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software […]
Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
Partnership to accelerate enrollment and diversity in neurovascular clinical research SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic partnership with Vastrax, the leading full-service, vascular clinical research organization (CRO). Together, Viz.ai and Vastrax will accelerate clinical trial enrollment for research on novel […]
Viz.ai Launches AI-Powered VizTM Cardio Suite
Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals CHICAGO & SAN FRANCISCO–(BUSINESS WIRE)–AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS– Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a full cardiology suite to speed and improve patient access to innovative […]
Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform
Partnership delivers critical insights to cardiac care teams for faster patient triage and care SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has partnered with Us2.ai, the developer of AI software that fully automates a complete echocardiography, or heart ultrasound, report. Under the […]
Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity SAN FRANCISCO–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ratio algorithm, a seamless […]